Lasa Supergenerics Ltd

  • BSE Code : 540702
  • NSE Symbol : LASA
  • ISIN : INE670X01014
  • Industry :PHARMACEUTICALS - INDIAN - BULK DRUGS & FORMLN

up-arrow 6.24 0.29(4.87%)

Open Price ()

6.19

Prev. Close ()

5.95

Volume (No’s)

14,116

Market Cap ()

31.26

Low Price ()

5.95

High Price ()

6.24

 

Book Closure

From Date To Date Announcement
13-Feb-2026 NA Lasa Supergenerics Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 13/02/2026 inter alia to consider and approve Pursuant to Regulation 29 of the Securities and Exchange Board of the India (Listing Obligation and Disclosure Requirement) Regulation 2015 notice is hereby given that Meeting of the Board of Directors of the Company is scheduled to be held on Friday February 13 2026 inter alia; 1. To consider approve and take on records Unaudited financial results of the Company for the quarter ended December 31 2025. 2. To discuss any other matter with the permission of the Chairperson. Pursuant to Regulation 29 and 30 of SEBI (Listing obligation and disclosure requirements) Regulations, 2015, we would like to inform you that the Board of Directors in their meeting held today which was commenced at 2.00 P.M. and concluded at 03.15 P.M. inter- alia have considered and approved the following: 1. The Unaudited Financial Results of the Company for the quarter ended December 31, 2025. 2. Limited Review Report from Statutory Auditor for the quarter ended on December 31, 2025. Results for quarter ended 31st December 2025 (As Per BSE Announcement Dated on:13.02.2026)
02-Jan-2026 NA Pursuant to Regulation 30 of SEBI (Listing obligation and disclosure requirements) Regulations, 2015, we would like to inform you that the Board of Directors in their meeting held today i.e . January 02, 2026 which was commenced at 2.00 p.m. and concluded at 4.00 p.m inter- alia have considered and approved the following: 1. Appointment of Mr. Ganesh Suresh Potdar as an Additional Director in Capacity of (Executive Director) and Occupier of All units of the Company. Further the aforesaid appointment shall be subject to approval of members at the ensuing General Meeting/ Postal Ballot of the Company
02-Jan-2026 NA Pursuant to Regulation 30 of SEBI (Listing obligation and disclosure requirements) Regulations, 2015, we would like to inform you that the Board of Directors in their meeting held today i.e . January 02, 2026 which was commenced at 2.00 p.m. and concluded at 4.00 p.m inter- alia have considered and approved the following: 1. Appointment of Mr. Ganesh Suresh Potdar as an Additional Director in Capacity of (Executive Director) and Occupier of All units of the Company. Further the aforesaid appointment shall be subject to approval of members at the ensuing General Meeting/ Postal Ballot of the Company
31-Dec-2025 NA We would llike to inform you that Mr. Prathmesh Chalke tendered his resignation as Whole-time Director of the Company .
16-Dec-2025 NA We wish to inform you that Mrs. Mitti Jain is hereby appoitned as Company secretary and Compliance Officer of the Company

Copyright © 2026 Arihant Capital Markets Ltd. All rights Reserved.

Designed, Developed and Content powered by CMOTS InfoTech (ISO 9001:2015 & ISO/IEC 27001:2022 Certified)

x
  • QR-CodeNew